Tag: FDA approval
Synapse Biomedical Wins New Approval for Diaphragm Pacing System to Free Patients from Ventilators
A major April 2023 development for the spinal cord injury community came with the announcement that Synapse Biomedical received FDA premarket approval for its...
Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use...
This March 2023 announcement marked an important practical milestone in spinal cord injury mobility technology. ReWalk Personal Exoskeleton received FDA clearance for use on...
